Tag: pharmaceutical industries

May 7, 2018

Is Another Cannabis Stock Rush Actually Coming?

Investors in the popular Canadian public cannabis space have waited for the next buying rush to come once the date...
May 7, 2018

The Green Organic Dutchman Assembles World Class Senior Leadership Team

The Green Organic Dutchman Holdings Ltd.’s (“TGOD”) (TSX:TGOD) is pleased to announce the addition of several key executives including CFO,...
April 3, 2018

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

BriaCell Therapeutics Corp. ("BriaCell") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to...
March 28, 2018

Valens GroWorks expands cannabis oil production capacity 600%

Valens GroWorks Corp. (CSE:VGW) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products, is pleased to announce...
March 27, 2018

BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology,...
March 9, 2018

Valens Groworks Commences Cannabis Oil Production

Valens GroWorks Corp (CSE:VGW), a multi-licensed, vertically integrated provider of cannabis products, is pleased to announce the successful completion of...
March 8, 2018

BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology,...